The company GB Sciences Inc. has obtained the exclusive global worldwide intellectual property license for this innovative solution, which is based on nanotechnology.

The researchers Lucía Martín Banderas and Mercedes Fernández Arévalo, from the I+DNanomed research group at the University of Seville, have patented an innovative formulation based on nanotechnology, which is designed to relieve chronic neuropathic pain. The company GB Sciences, Inc. has obtained the exclusive global intellectual property license for the use of this patent.

This research group, in collaboration with the researchers J.A. Micó and E. Berrocoso, of the University of Cadiz and the Mental Health Networking Biomedical Research Centre (CIBERSAM), has shown that its formulation of controlled liberation of a derived cannabinoid provides neuropathic pain relief in rats for a period of eleven days after the oral administration of a single dose. Part of the results of this project have recently been published in the review Nanomedicine: Nanotechnology, Biology and Medicine.

Read more at news medical life sciences

Image Credit:  Fotalia

Recent News

A megalibrary of nanoparticles

Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six [...]

Self-driving microrobots

Most synthetic materials, including those in battery electrodes, polymer membranes, and catalysts, degrade over time because they don't have internal repair mechanisms. If you could distribute autonomous microrobots within [...]